Manufacturing, Cell Culture and Fermentation

Jumping Seed Train Intensification Hurdles to Maximize Yield

March 02, 2021

Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.

Fujifilm to Invest Over $2 Billion into US Biopharmaceutical Manufacturing Facility

January 07, 2021

The new facility, which will be operated by Fujifilm Diosynth Biotechnologies, will provide large-scale cell-culture manufacturing of bulk drug substance with 8 x 20,000-L bioreactors.

Cultivating a Synthetic Biology-Based Approach to Improving Cell Culture

January 02, 2021

Cell-culture optimization may see benefits from a synthetic biology-based approach that improves product titer, quality, and time.

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center

October 29, 2020

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.

New EpiMOGRIFY Technology Platform Offers Development Support for Allogeneic Cell Therapies

October 29, 2020

Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.

MilliporeSigma Launches Lentiviral Production Platform for Cell and Gene Therapies

October 16, 2020

The new VirusExpress lentiviral production platform increases dose yields and reduces process development time for cell and gene therapies.

Current Challenges with Cell Culture Scale-up for Biologics Production

October 02, 2020

Bioreactor technology advances can offer seamless manufacturing scale-up and can reduce the timeline and cost of biologics production.

Cytiva Invests $500 Million Over 5 years to Expand Global Capacity

September 14, 2020

The investment will include new manufacturing lines and increased automation to deliver additional manufacturing capacity.

Samsung Biologics Expands Manufacturing Facilities and Launches Cell Line Technology

August 13, 2020

The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.

Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow

July 02, 2020

Innovative approaches, including ready-to-use materials and in-line dilution, can significantly streamline overall bioprocessing operations.